Table 2.
Clinical characteristics among the studied group of patients
| M group (n = 24) | Non-M group (n = 20) | |
|---|---|---|
| Sex M/F | 14/10 | 16/4 |
| Age (years)a | 62.5 (10–81) | 66 (40–90) |
| Number of lesions | 29 | 25 |
| History of malignancy (n) | 24 | 18 |
| Malignant lymphoma | 7 | 1 |
| Head and neck cancer | 3 | 2 |
| Lung cancer | 4 | 3 |
| Breast cancer | 3 | 0 |
| Gastrointestinal cancer | 3 | 8 |
| Others | 4 | 5 |
| Location of bone marrow lesion | ||
| Spine (cervical/thoracic/lumbar /sacrum) | 2/3/6/1 | 0/7/2/4 |
| Pelvic bone (ileum/pubis/ischium) | 6/1/0 | 4/0/2 |
| Femur | 6 | 6 |
| Others | Scapula (1), humerus (3) | 0 |
| RBC (104/µL)a | 432 (327–533) | 401 (310–482) |
| Hb (g/dL)a | 12.2 (9.3–15.9) | 13.0 (8.9–15.3) |
| Hct (%)a | 37.5 (29.4–47.0) | 38.9 (30.0–45.8) |
| History of chemotherapy (n) | 7 | 3 |
| History of GCSF administration (n) | 0 | 0 |
| MR unit (GE/Siemens) | 4/20 | 6/17 |
aData are the median (min. to max.)